4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-027342
Director sold 105,000 shares at $15.40 ($1,617,000)
- Director acquired 105,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hutson Nancy J · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-15 | Exercise or conversion : show line 1 in the form | +30,000 | $2.91 | $87,300 | 95,073 | D |
| 2021-10-15 | Exercise or conversion : show line 2 in the form | +30,000 | $5.13 | $153,900 | 125,073 | D |
| 2021-10-15 | Exercise or conversion : show line 3 in the form | +15,000 | $1.71 | $25,650 | 140,073 | D |
| 2021-10-15 | Exercise or conversion : show line 4 in the form | +30,000 | $3.22 | $96,600 | 170,073 | D |
| 2021-10-15 | Sale : show line 5 in the form | −105,000 | $15.40 | $1,617,000 | 65,073 | D |
| Open-market sales · 105,000 sh · avg $15.40 · $1,617,000 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-15 | Exercise or conversion : show line 6 in the form Automatic Stock Option Grant | −30,000 | 0 | D |
| 2021-10-15 | Exercise or conversion : show line 7 in the form Automatic Stock Option Grant | −30,000 | 0 | D |
| 2021-10-15 | Exercise or conversion : show line 8 in the form Automatic Stock Option Grant | −15,000 | 0 | D |
| 2021-10-15 | Exercise or conversion : show line 9 in the form Automatic Stock Option Grant | −30,000 | 0 | D |
Loading xslF345X03/form4.xml…